Am I Eligible for Mounjaro or GLP-1 Weight Loss Medication?

You are most likely to be considered a candidate if you are:

• An adult (18+), not pregnant or breastfeeding.
• At a BMI of 30 or higher (obesity), or
• At a BMI of 27 or higher with a weight-related condition — type 2 diabetes, prediabetes, PCOS, fatty liver, hypertension, sleep apnoea or high cholesterol.

Eligibility is a clinical judgement, not a single number. The same criteria apply whether a doctor is considering tirzepatide (Mounjaro) or semaglutide (Wegovy, Ozempic) — see Mounjaro vs Ozempic for how the medicines differ.

BMI = weight (kg) ÷ height (m²). Standard global ranges call 25–30 “overweight” and 30+ “obese”. But BMI was derived from European populations, and it travels badly. At the same BMI, South Asians carry more body fat and less lean muscle, and store more liver and abdominal fat.

A WHO expert consultation identified 23 kg/m² as a public-health action point for Asian populations, and Indian thresholds treat 23+ as overweight and 25+ as obesity. That is why someone with a BMI of 24 — “normal” on a Western chart — can already have insulin resistance, fatty liver and a worrying lipid profile. Check yours with our BMI calculator using Indian cutoffs.

Waist circumference is often more informative than BMI, because it approximates visceral fat — the fat around the organs that drives insulin resistance. Two people with the same BMI can carry very different risk.

Yes — diabetes is not a requirement. Tirzepatide and semaglutide have been studied specifically for weight management in adults without diabetes (the SURMOUNT-1 and STEP 1 trials), and doctors prescribe them for obesity on its own. Safety depends on your history rather than on whether you have diabetes: the screening questions below matter far more.

What a doctor does watch for in non-diabetics is different from diabetics on insulin: dehydration from nausea, adequate protein to protect muscle, and gradual dose increases. See Mounjaro side effects for what to expect.

GLP-1 medication is generally not appropriate if you:

• Are pregnant, breastfeeding or planning pregnancy soon.
• Have a personal or family history of medullary thyroid cancer or MEN2.
• Have a history of pancreatitis or certain gallbladder disease.
• Have specific severe gastrointestinal conditions.

These medicines are also not for cosmetic weight loss at a healthy weight, and not a substitute for treating an underlying cause — if undiagnosed hypothyroidism is driving weight gain, the thyroid needs treating first. More on rare but serious risks in GLP-1 safety risks.

An assessment that only weighs you is incomplete. A doctor looks at:

• BMI and waist circumference together
• Fasting glucose and HbA1c — is there prediabetes or undiagnosed diabetes?
• Lipid profile and blood pressure
• Thyroid function
• Liver markers, given how common fatty liver is in India
• Personal and family history, including gallbladder disease and thyroid cancer
• Current medications, particularly insulin or sulfonylureas
• Whether you are planning a pregnancy

Having recent reports ready speeds this up. The steps to getting a legitimate prescription are in how to get a Mounjaro prescription in India.

No. Several obesity-related conditions have their own evidence. Semaglutide reduced major adverse cardiovascular events by 20% in people with overweight or obesity and established cardiovascular disease in the SELECT trial. Tirzepatide improved obstructive sleep apnoea in SURMOUNT-OSA. Semaglutide reduced knee osteoarthritis pain in STEP 9. If you have one of these conditions, raise it specifically.

Equally, medication is not always the answer. In the Diabetes Prevention Program, lifestyle change reduced progression to type 2 diabetes by 58% in people at high risk. Many people are appropriately treated without medication at all.

• Appetite and “food noise” quieten for most people once treatment settles in.
• Early side effects are usually digestive — nausea, bloating, constipation — and are minimised by starting at a low dose and increasing slowly. See the Mounjaro dosage chart.
• It works best as part of a programme. Medication reduces appetite; it does not fix protein intake, strength, sleep or stress. That is where nutrition and coaching come in.